These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32031616)

  • 1. Presence of PTPN2 SNP rs1893217 Enhances the Anti-inflammatory Effect of Spermidine.
    Niechcial A; Butter M; Manz S; Obialo N; Bäbler K; van der Lely L; Lang S; Gottier C; McCole DF; Scharl M; Spalinger MR
    Inflamm Bowel Dis; 2020 Jun; 26(7):1038-1049. PubMed ID: 32031616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crohn's disease-associated polymorphism within the PTPN2 gene affects muramyl-dipeptide-induced cytokine secretion and autophagy.
    Scharl M; Mwinyi J; Fischbeck A; Leucht K; Eloranta JJ; Arikkat J; Pesch T; Kellermeier S; Mair A; Kullak-Ublick GA; Truninger K; Noreen F; Regula J; Gaj P; Pittet V; Mueller C; Hofmann C; Fried M; McCole DF; Rogler G
    Inflamm Bowel Dis; 2012 May; 18(5):900-12. PubMed ID: 22021207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Relevance of the IBD-Associated Variation within the Risk Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 2 in Patients of the Swiss IBD Cohort.
    Spalinger MR; Voegelin M; Biedermann L; Zeitz J; Rossel JB; Sulz MC; Frei P; Scharl S; Vavricka SR; Fried M; Rogler G; Scharl M;
    Digestion; 2016; 93(3):182-92. PubMed ID: 26928573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of protein tyrosine phosphatase non-receptor type 2 by spermidine exerts anti-inflammatory effects in human THP-1 monocytes and in a mouse model of acute colitis.
    Morón B; Spalinger M; Kasper S; Atrott K; Frey-Wagner I; Fried M; McCole DF; Rogler G; Scharl M
    PLoS One; 2013; 8(9):e73703. PubMed ID: 24040033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spermidine stimulates T cell protein-tyrosine phosphatase-mediated protection of intestinal epithelial barrier function.
    Penrose HM; Marchelletta RR; Krishnan M; McCole DF
    J Biol Chem; 2013 Nov; 288(45):32651-32662. PubMed ID: 24022492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTPN2 Regulates Interactions Between Macrophages and Intestinal Epithelial Cells to Promote Intestinal Barrier Function.
    Spalinger MR; Sayoc-Becerra A; Santos AN; Shawki A; Canale V; Krishnan M; Niechcial A; Obialo N; Scharl M; Li J; Nair MG; McCole DF
    Gastroenterology; 2020 Nov; 159(5):1763-1777.e14. PubMed ID: 32652144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients.
    Yilmaz B; Spalinger MR; Biedermann L; Franc Y; Fournier N; Rossel JB; Juillerat P; Rogler G; Macpherson AJ; Scharl M
    PLoS One; 2018; 13(7):e0199664. PubMed ID: 29965986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of
    Shaw AM; Qasem A; Naser SA
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cell type-specific role of protein tyrosine phosphatase non-receptor type 2 in regulating ER stress signalling.
    Kasper SH; Spalinger MR; Raselli T; Scharl M
    Digestion; 2015; 91(3):248-56. PubMed ID: 25823847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of protein tyrosine phosphatase N2 potentiates epidermal growth factor suppression of intestinal epithelial chloride secretion.
    Scharl M; Rudenko I; McCole DF
    Am J Physiol Gastrointest Liver Physiol; 2010 Oct; 299(4):G935-45. PubMed ID: 20689057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTPN2 rs1893217 single-nucleotide polymorphism is associated with risk of Behçet's disease in a Chinese Han population.
    Wu Z; Chen H; Sun F; Xu J; Zheng W; Li P; Chen S; Shen M; Zhang W; Li M; You X; Wu Q; Zhang F; Li Y
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S20-6. PubMed ID: 24480412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell protein tyrosine phosphatase protects intestinal barrier function by restricting epithelial tight junction remodeling.
    Marchelletta RR; Krishnan M; Spalinger MR; Placone TW; Alvarez R; Sayoc-Becerra A; Canale V; Shawki A; Park YS; Bernts LH; Myers S; Tremblay ML; Barrett KE; Krystofiak E; Kachar B; McGovern DP; Weber CR; Hanson EM; Eckmann L; McCole DF
    J Clin Invest; 2021 Sep; 131(17):. PubMed ID: 34623320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of epithelial barrier function by the inflammatory bowel disease candidate gene, PTPN2.
    McCole DF
    Ann N Y Acad Sci; 2012 Jun; 1257():108-14. PubMed ID: 22671596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine phosphatase non-receptor Type 2 regulates IFN-γ-induced cytokine signaling in THP-1 monocytes.
    Scharl M; Hruz P; McCole DF
    Inflamm Bowel Dis; 2010 Dec; 16(12):2055-64. PubMed ID: 20848498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The JAK inhibitor, Tofacitinib, Corrects the Overexpression of CEACAM6 and Limits Susceptibility to AIEC Caused by Reduced Activity of the IBD Associated Gene,
    Chatterjee P; Canale V; King SJ; Shawki A; Lei H; Haddad M; Gries CM; McGovern DPB; Borneman J; McCole DF
    medRxiv; 2024 Sep; ():. PubMed ID: 39399045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein tyrosine phosphatase non-receptor type 2 and inflammatory bowel disease.
    Spalinger MR; McCole DF; Rogler G; Scharl M
    World J Gastroenterol; 2016 Jan; 22(3):1034-44. PubMed ID: 26811645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The JAK Inhibitor Tofacitinib Rescues Intestinal Barrier Defects Caused by Disrupted Epithelial-macrophage Interactions.
    Spalinger MR; Sayoc-Becerra A; Ordookhanian C; Canale V; Santos AN; King SJ; Krishnan M; Nair MG; Scharl M; McCole DF
    J Crohns Colitis; 2021 Mar; 15(3):471-484. PubMed ID: 32909045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of epithelial barrier function by the Crohn's disease associated gene protein tyrosine phosphatase n2.
    Scharl M; Paul G; Weber A; Jung BC; Docherty MJ; Hausmann M; Rogler G; Barrett KE; McCole DF
    Gastroenterology; 2009 Dec; 137(6):2030-2040.e5. PubMed ID: 19818778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4(+) T cells.
    Long SA; Cerosaletti K; Wan JY; Ho JC; Tatum M; Wei S; Shilling HG; Buckner JH
    Genes Immun; 2011 Mar; 12(2):116-25. PubMed ID: 21179116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the PTPN2 gene and Crohn's disease: dissection of potential causal variants.
    Marcil V; Mack DR; Kumar V; Faure C; Carlson CS; Beaulieu P; Israel D; Krupoves A; Costea I; Lambrette P; Grimard G; Dong J; Seidman EG; Amre DK; Levy E
    Inflamm Bowel Dis; 2013 May; 19(6):1149-55. PubMed ID: 23518806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.